Comparative effectiveness of dupilumab and JAK inhibitors in atopic dermatitis: Dose reduction compromises efficacy of JAK inhibitors—The CORNERSTONE study

Journal of the American Academy of Dermatology · Published 2026-08-01 · DOI 10.1016/j.jaad.2026.07.024

Free full text

Authors (4)

Ruojun Wang, Zhihui Yang, Hang Li, Yang Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wang, R., Yang, Z., Li, H., et al. (2026). Comparative effectiveness of dupilumab and JAK inhibitors in atopic dermatitis: Dose reduction compromises efficacy of JAK inhibitors—The CORNERSTONE study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.024

Related articles